Promoter methylation of RASSF1A, RARbeta and DAPK predict poor prognosis of patients with malignant mesothelioma. (Q54588377)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Promoter methylation of RASSF1A, RARbeta and DAPK predict poor prognosis of patients with malignant mesothelioma. |
scientific article |
Statements
Promoter methylation of RASSF1A, RARbeta and DAPK predict poor prognosis of patients with malignant mesothelioma. (English)
1 reference
Jürgen R Fischer
1 reference
Ute Ohnmacht
1 reference
Norman Rieger
1 reference
Marius Zemaitis
1 reference
Clemens Stoffregen
1 reference
Michael Kostrzewa
1 reference
Erika Buchholz
1 reference
Christian Manegold
1 reference
Harald Lahm
1 reference
7 August 2006
1 reference
1 reference
54
1 reference
1
1 reference
109-116
1 reference
Identifiers
1 reference